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INTRODUCTION: 
The interrelationship of the thyroid gland and the cardiovascular- 
system has been known since the early nineteenth century. Hyperthyroi¬ 
dism, hy increasing oxygen consumption, can cause an almost concomitant 
rise in cardiac output. The arterial pulse pressure in hyperthyroidism 
is increased because of an elevation of systolic pressure and a decrease 
in peripheral resistance. 
Interest in the relationship between the thyroid and hypertension, 
therefore, was natural following the description by Goldblatt _et al 
(193*0 of a mechanism for the production of persistent elevation of 
systolic blood pressure by means of renal ischemia in dogs, 
l) Hypertensive Studies in Dogs: 
Page and Sweet (1937)? confirmed by Braun-Menendez (1952), showed 
that dessicated thyroid (0.8 Grams) raised moderately the pressure of 
hypertensive dogs whose pressure had previously been reduced by hypo- 
physectomy. Glenn and Lasher (1938)? however, using the Goldblatt 
clamp, found that thyroidectomy caused no significant fall in blood 
pressure and that the application of the clamp after thyroidectomy was 
followed by a well sustained rise in the dogs* blood pressure. Blood 
cholesterol was used as an index of severity of myxedema. These findings 
were confirmed by Katz et al (1939)* 
Page and Sweet (1937) bad postulated that the responsiveness of 
blood vessels to chemical stimuli from the kidney was secondary to an 
increase or decrease of thyroid or adrenal secretions. Testing the effect 
of the athyroid state on vascular reactivity and arterial pressure in 
renal hypertensive dogs. Page and McCubbin (1952) showed that vascular- 
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reduced -with suppression of thyroid function in normotensive dogs. The 
possibility that suppression of thyroid function in renal hypertensive 
animals might be associated with a decrease in arterial blood pressure 
was not confirmed (McCubbin and Page, 1952) and changes of vascular 
reactivity were slight in comparison with those of normotensive dogs. 
Eleven out of seventeen dogs with Goldblatt hypertension were 
found by Wakerlin et al (1957) to have a decrease in systolic blood 
pressure when fed diets containing thiouracil and rich in cholesterol. 
How much of the fall was due to either of the substances singly was un¬ 
clear because when given individually neither had an effect on the two 
hypertensive dogs on each treatment. 
Brull and Op de Beek (unpublished) observed no increase in basal 
metobol'ic rate in dogs made hypertensive by the Goldblatt technique. 
Brull and Merchie (1958), however, found a progressive increase in 
thyroid activity (protein bound iodine) in renal hypertensive dogs. 
The PBI was greater later in the course of the experiment than earlier 
despite the progressive decrease of blood pressure at the end. The 
technique used in these experiments was unilateral nephrectomy and 
clamping of the contralateral renal artery. How much significance may 
be attached to the increased PBI is undetermined since nephrectomy alone 
is a stimulus for increased thyroid secretion. 
On the basis of the experiments performed on dogs, the thyroid 
gland would seem to play no important role in either the maintenance 
or genesis of renal hypertension. This does not mean that there does 
not exist a close relationship between the thyroid and experimental 
renal hypertension in other animals; and indeed this has been shown 





2) Hypertensive Studies in Eats: 
Wastl (1945) studied the influence of two thiourea derivatives 
on blood pressure in hypertensive rats. The substances used caused 
a decrease in blood pressure in hypertensive rats but not in normals. 
The blood pressure drop occurred during four days of intraperitoneal 
injections and returned to preinjection levels within four days. 
Although response was said to vary with the dose, it is puzzling 
that the antithyroid effect should have been achieved so rapidly. 
Bachtold (1950) found that methyl-thiouracil had no influence 
on the blood pressure of normal rats, but that it decreased blood 
pressure in renal hypertensive rats only during the course of treatment. 
Similarly treatment before hypertension was produced only delayed the 
appearance of hypertension. 
Thyroxine at a dose of 10 mg per kg per os or 1 mg per kg s.q. 
caused a rise in blood pressure in normal animals from 110 to 142 in 
two weeks and then a decline to 124 after eight weeks, at which time 
treatment was ended. After thirteen weeks, the blood pressure was 
back to normal. In hypertensive animals, the blood pressure was ele¬ 
vated from 170 to greater than 230, leading to death. Thyroxine also 
prevented the decrease of blood pressure in hypertensive rats treated 
with methyl-thiouracil. 
In animals subjected to figure-of-eight ligature of one kidney 
and extirpation of the other, given Vfo saline to drink, thyroidectomy 
orthiouracil decreased hypertensive blood pressure levels almost to 
normal (Braun-Menendez, 1954). In rats with moderate reduction in 







hypertension almost to normal. Thyroid powder (.15-25 mg per day) or 
thyroxine (40 pg s.q. per day) increased the blood pressure of normo- 
/ 
tensive animals with moderate renal mass reduction, and with some 
persistence of the increased blood pressure after therapy. 
Braun-Menendez and Penhos (1955) found that thyrotropic hormone 
raised blood pressure in normotensive or moderately hypertensive rats 
with reduced renal mass, causing a rise to hypertensive levels. The 
effect was not observed in thyroideeternized animals. 
Using high doses of tri-iodo-thyronine, Zadunaisky (1957* i960) 
showed no increase in the blood pressure of normal rats but an increase 
in those rats with reduced renal mass (unilateral nephrectomy, figure” 
of-eight ligature and 1 fo saline to drink) during the silent period 
before hypertension developed. The test of radioactive iodine uptake 
by the thyroid gland after 2k hours in stable hypertensive and normo¬ 
tensive control animals showed no appreciable difference. This would 
implicate the thyroid in the developmental period of hypertension. 
Osorio (l95o) testing vascular reactivity in normal, hypo- and 
hyperthyroid rats found that rats treated with thyroid powder showed 
slightly less sensitivity to pressor drugs than normals. The decreased 
sensitivity of the hypothyroid group was greater. When the hypothryoid 
group was treated with vasodepressors they were more sensitive than the 
normals. This latter finding is in agreement with that of Page and 
McCubbin (1952) in dogs. 
A short communication by Martin and Lehr (1955) reported that 
thyroid-parathyroidectomy in rats with renal obstruction delayed the 
emergence of hypertension. 
Krieger (1956) discovered that thyroid powder (30 mg per day per 













"blood pressure in normal rats over a. period of three weeks, whereas 
the same treatment in rats with reduced renal mass(figure-of-eight 
ligature and unilateral nephrectomy) caused a significant rise in 
blood pressure. 2-4 Dinitrophenol had no renotrophic or hypertensive 
effect although it shared with thyroxine an augmentation of oxygen 
consumption. 
Recently Fhegly and his colleagues (Fregly, 1958; Fregly and 
Hood, 1959; and Iregly, Baker and Gennaro, i960) have explored the 
effects of propyl-thiouracil, as well as thyroidectomy, in the 
development and maintenance of renal hypertension in rats. PTU pre¬ 
vented or removed hypertension associated with bilateral, kidney 
encapsulation with latex envelopes; however, the effect was not 
permanent. This treatment also decreased blood pressure in normal 
non-encapsulated rats. The systolic blood pressure of established 
hypertensive females was not significantly effected by surgical 
thyroid-parathyroidectomy; although this treatment did prevent a 
rise in blood pressure to hypertensive levels. As with PTU, thyroid- 
parathyroidectomy reduced blood pressure in normal unoperated controls. 
PTU could not decrease further the blood pressure of thyroid-para- 
thyroidectomized rats over a long period of time, although there was 
an early transient decrease. 
Fregly and Cook (i960) confirmed earlier work that the antithyroid 
drugs, thiouracil, propylthiouracil and methimazole, prevented both 
the development of increased blood pressure and cardiac hypertroiohy 
which usually accompanied kidney encapsulation with latex envelopes. 
The drugs also reduced the increased blood pressure in rats with hyper¬ 
tension of 13 to 40 weeks duration prior to drug administration. 
Addition of dessicated. thyroid powder to the diet containing the anti¬ 










Withdrawal of thyroid powder was followed by return of the blood 
pressure to previous low levels. The anti-hypertensive effect of 
the antithyroid drugs was attributed to decreased thyroid secretion 
rathar. than the extrathyroidal effects of the antithyroid drugs, eg, 
decreased food intake, anemia, polydipsia, etc. 
Thyroid activity as assessed by the ratio of thyroid weight to 
131 
body weight, precipitate to serum I ratio, and mean thyroid acinar 
cell height, increased sharply as the systolic blood pressure approached 
the high normal or low hypertensive range (Fregly and Gonzales 1961). 
The differences shown by dogs and rats may perhaps be explained 
by the fact that.although minor degrees of clinical hypothyroidism 
can be produced readily in dogs, myxedema is rare. The dog is unusual 
in that it is relatively insensitive to both excess and deficit of 
thyroidal hormone. Brewster et al (195*0 found no significant increase 
in mean arterial blood pressure in dogs fed 0.8 grams per kilogram of 
thyroid for a period of three weeks, (compare with Page and Sweet 1937)* 
The work that has been done in Europe by Wastl and Bachtold, in 
South America by Braun-Menendez, Penhos, Osorio and Zadunaisky and in 
the United States by Fregly would clearly indicate the existance of a 
relationship between the genesis of experimental renal hypertension 
in rats by the Goldblatt and related techniques and thyroid function. 
Decrease in thyroid function does not prevent the occurrence of hyper¬ 
tension. The effect of the thyroid on maintenance of established renal 
hypertension would seem of less importance. 
In addition to the Goldblatt technique, experimental hypertension 
has been established by chronic administration of corticosteroids in 
large doses or in smaller doses by concomitant administrations of saline 
6 
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and/or renal injury. Selye (1950) showed that thyroxine at a dose 
of 2 mg per day might be substituted for desoxycorticosterone acetate 
in the production of nephrosclerosis and hypertension by a combination 
of DOCA, rp saline as drinking water and unilateral nephrectomy. 
The Thyroid in Metacorticoid Hypertension 
Selye (1953) determined that thyroidectomy protected considerably 
but incompletely against the toxic effects of DOGA. In particular it 
decreased the power of DOGA to produce hypertension. Thyroxine (Selye 
and Bois, 195&) was shown to act as a sensitizing agent in the pro¬ 
duction of renal and cardiovascular lesions with steroids. 
Hypophysectoiny inhibited all the manifestations of DOCA overdosage 
(Salgado and Selye, 1953); but the effects of thyroidectomy were nearly 
as complete. Thyroidectomy at the beginning of DOCA treatment (Salgado 
and Green, 1956; Salgado, 1953) prevented hypertension, but after the 
establishment of DOCA hypertension, its effect was only short lived. 
Thyroid-parathyroidectomy (Salgado and Selye, 195^0 had a dissociative 
effect on the cardiovascular and renal changes caused by methyl 
androstenediol, inhibiting the production of hypertension. The effects 
of thiouracil (Salgado, 195^) were found to be similar to thyroidectomy. 
The significance of steroid hypertension has been debated because 
of the extreme conditions, i.e. the high dose of steroids, necessary to 
produce it. It would be safe to conclude., however, as did Green et al 
(1952) and Salgado and Green (1957); that the thyroid might play a 
significant role in the development of DOGA hypertension. Suppression 









Mechanisms of Thyroid Action in Renal hypertension 
1) Vascular Reactivity 
2) Direct Effect: Kidney Growth and Function 
3) Indirect Effect: Mediated Through the Adrenals 
4) The Renotropin Hypotnesis 
1) Vascular Reactivity 
A frequently discussed possibility is that the thyroid hormone 
acts on the calibre of the renal vessels either directly or through 
a change of vascular reactivity to various pressor agents. Sawyer and 
Brown (1935) and Aumann et al (1940) found an altered sensitisation of 
the adrenergic neuroeffector systems by the thyroid hormone. They 
found no increase in medullary output secondary to hyperthyroidism. 
Brewster(195^) discovered that the cardiovascular effects of 
thyrotoxicosis were not due to the direct effect of thyroxine per se 
but rather to an augmentation of the physiological effects of epineph¬ 
rine and norepinephrine by thyroxine. The changes produced by increased 
concentrations of thyroid hormone were cfcbolished by preventing the 
reflex release of epinephrine and norepinephrine with a total sympa¬ 
thetic block. (Brewster et al 1956)• Roskowski (1956) discovered 
that medial necrosis produced by large i.v. injections of epinephrine 
was not produced in thyroidectomized animals. 
Page and McCabbin (1952) found that vascular responsiveness to 





dependent on thyroid activity. Thyroidectomy suppressed vascular 
reactivity to a number of substances in normal animals but had little 
or no effect in established hypertension. Osorio (1956) found that rats 
treated with thyroid powder showed a little less sensitivity to pressor 
drugs when compared with normals and the hypothyroid animals showed 
a considerable decrease in sensitivity. The decrease was quite marked 
in hypothyroids treated with depressor substances. 
The experiments on vascular reactivity tend to show differences 
in vessel reactivity in normal or early hypertensives to that in 
established hypertensives. These results are in agreement with those 
which demonstrate a greater and more prolonged reaction of blood 
pressure to various treatments in animals which are in the silent 
period preceding hypertension or already have mild early hypertension. 
2. Direct Effect: Kidney Growth and Function 
The positive effect of the thyroid on kidney growth is well known 
(iscovesco, 1913> Hoskin, 1910, 1916; Hewitt, 1920; quoted in Cameron 
1920. This renotrophic activity was shown by Swann (1939) to be present 
in the absence of the pituitary. Antithyroid drugs were discovered to 
produce a decrease in renal weight (Cottet et al, 1951)• 
Unilateral nephrectomy caused an increase in thyroid secretion 
(Brull and Merchie, 1958); and thyroxine (Dragoni, 1952) increased 
compensatory renal hypertrophy in normal rats, although thyroidectomy 
did not completely prevent such hypertrophy (Zeckwer et al, 1946). 
The thyroid-pituitary axis was proved relatively unimportant since 
hypophysectomy did not prevent compensatory renal hypertrophy (Braun- 
Menendez and H.E.J. Houssay, 1959)* 
9 
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Ogawa (1958) found a mitosis stimulating factor in the serum of 
unilateral nephrectomized rats. Mandel et al (1953) working on experi¬ 
mental nephritis showed that thyroxine favored cell repair. 
Fateeva (quoted in Brull and Merchie, 1958), using I 0 uptake, 
and Brull and Merchie (1958), using FBI, demonstrated an increase in 
thyroid secretion to renal ischemia. Albright et al (l95^)> among 
others, had shown that kidney slices could metabolize thyroxine to tri- 
iodo-thyronine; and using time reponse tissue studies in thyroxine 
injected rats, Barker and Klitguard (1952) found that no tissue was 
specifically dependent on another to increase its energy metabolism 
turn-over in response to thyroxine. Since 2, 4-dinitrophenol shared 
with thyroxine its actions on oxygen consumption but not on kidney 
growth, Krieger (1956) could postulate that the hypertensive effect of 
thyroxine was due to its renotrophic action. Dumont (19^-3) showed that 
ischemia of transplanted cervical kidneys pretreated with thyroxine 
yielded a greater increase in blood pressure than did ischemia of 
transplanted normal kidney. 
3. Indirect Effect: Mediated Through the Adrenals 
Favoring an indirect mechanism for thyroid action in renal 
hypertension, Selye (1950, 1953) and Salgado andSelye (195^) proposed 
that thyroxine produced kidney lesions and hypertension by means of 
an increased production of mineralocorticoids. Thyroidectomy decreased 
adrenalcorticoid production. 
Green et al (1952) and Fregly and his co-workers (1958-60) main¬ 
tained that certain forms of experimental hypertension did not involve 
10 





adrenal cortical activity and that propylthiouracil’s effect on blood 
pressure was not due to hypofunction of the adrenals. Fregly was able 
to obtain renal hypertension in the face of bilateral adrenalectomy, 
confirming earlier work by Fasciolo, 1938. 
Several authors (Bauman and Marine, 1945; Deane and Greep, 1947; 
Freedman and Gordon, 1950; Farrow and Money, 1949), however, found 
that propylthiouracil or thyroidectomy decreased adrenal size. But 
Bosenfield (1952) showed that thyroxine added to artificial perfusate 
of calf adrenals gave no acute increase or decrease in adrenal cortical 
activity. Chappel et al (1958) demonstrated that the weights of adrenals 
of PTU treated animals were not significantly less than hypertensives 
when expressed in terms of body weight, but a definite histological 
difference, i.e. shrinking of the zona fasciculate was seen. This 
latter finding confirmed the work of Deane and Greep (1947). Whether 
this was an effect of changed ACTH secretion or direct action of 
thyroxine is not known. Martin (1955) wrote of a lack of substantial 
adrenal hypertrophy following obstruction nephropathy in thyroid- 
parathyroidectomized dogs. 
In a recent work on the thyroid gland in the development and 
maintenance of renal hypertension (Fregly and Cook, i960) the increase 
in thymus weight ratio which usually accompanied adrenal hypofunction 
failed to manifest itself after treatment with antithyroid drugs. 
There was also no observed difference with respect to adrenal cholesterol 
concentration between encapsulated and non-encapsulated kidneys of 





4) The Henotropin Hypothesis 
Braun-Menendez (1952, 1958) sought to Bring together all work on 
experimental renal hypertension hy postulating the existence of a substance 
probably connected with intermediary metabolism. Be suggested that the 
kidney existed in a relationship Between certain demands which the Body 
might impose and its capacity to respond to them. For example, the 
adrenals responded to ACTH and the thyroid to T3H. This substance or group 
of substances, which has not Been isolated, regulated kidney growth and 
function and was named Renotropin. Its rate of production increased under 
the influence of hormones of the anterior pituitary, gonads and thyroid. 
Normally there existed an equilibrium Between the production of Renotropin 
and its destruction, transformation or utilization By the kidney, Increase 
of Renotropin caused kidney hypertrophy and decrease led to atrophy. When 
the equilibrium was disrupted and the remaining kidney tissue was unable 
to respond to the stimulus of normal or increased amounts of Renotropin 
present in the Blood, hypertension developed. The mechanism whereby 
hypertension results is unknown, although it may Be through secretion of 
renin. 
According to the Renotropin Hypothesis any of several hormones and 
a high protein diet were capable of interrupting the equilibrium between 
Renotropin production and a kidney unable to respond by reason of a 
figure-of'-eight ligature, thus causing an increase in blood pressure. 
Because most of the body’s hormones and diet exerted an Influence on 
blood pressure of renal ischemic origin, Braun-Menendez felt that these 




Recently Toth and Bartfai (i960), after establishing renal ischemic 
hypertension in parabiotic rats, were able to show an antihypertensive 
effect in the plasma of the rat with intact kidneys. 
Berlant (19-4-9) showed that excess protein or thyroid treatment 
caused their greatest hypertrophy in the brush segment of the nephron 
where absorption of glucose and other metabolites occurs. The effect 
of the thyroid was secondary to its increasing of substances such as 
glucose in the blood stream and its greater reabsorption of such 
substances by virtue of its hypertrophic response on the nephron. 
Hoffman et al (194-8) showed that adrenalectomy decreased oxygen 
consumption in rats by 10$. Adrenalectomy and thyroidectomy decreased 
oxygen consumption by 20$. The effect of thyroxine on metabolic rate 
was decreased in adrenalectomized rats. Administration of cortical 
extract to adrenalectomized rats allowed a normal metabolic response 
to thyroxine. Hoffman et al (194-9 a b ) found that thyroxine injected 
adrenalectomized rats did not show the elevation of urinary nitrogen 
observed in the controls. This was also observed in rats adrenal¬ 
ectomized following thyroid therapy. If increased urinary nitrogen 
was taken as a measure of increased protein metabolism, then the 
adrenalectomized rat was incapable of participating in the usual 
metabolic acceleration induced by thyroxine. 
Handler and Bernhein (l95l) studying the effects of caloric 
restriction and the role of the adrenals in renal hypertension showed 
a decrease in blood pressure in animals fed a low protein diet and 




The experiments of Heriant, Hoffman and Handler, although by no 
means definitive, would tend to support a unifying hypothesis such as 
that of Braun-Menendez in regard to the relationship between interne-” 
diary metabolism and renal hypertension. 
The experiments reported in this paper were undertaken to further 
delineate the interrelationship of the thyroid and adrenal glands in 
experimental renal hypertension, especially during the silent period 
after the reduction of renal mass and before the appearance of 
hypertension. This is the period when most of the factory concerned 
with the production of hypertension would seem to be most active. 
14 
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Materials and Methods: 
white Male rats of the Institute strain were used except for 
Experiment 5 where white male histar rats from the Argentine Atomic 
Energy Commission were employed. All animals were kept on the standard 
\ 
chow diet of the Institure. Tap water was given ad lib; during the 
course of the experiments this was changed to Ufa saline. In several 
experiments the saline consumption during the elapsed period was 
measured. 
Blood pressure was determined using the plethysmographic technique 
of Williams, Harrison and Grollman (1939 )j> slightly modified and using 
light ether anesthesia, Fig 1. Each animal’s blood pressure on a 
given day was taken as the mean of three consecutive measurements. 
Figure-of-eight ligature of the left kidney was performed according 
to the technique of Grollman (1944). Contralateral nephrectomy was 
usually done one week following. Left adrenalectomy was accomplished 
simultaneous with the ligature of the left kidney; and right adrenal¬ 
ectomy, with the right nephrectomy. In Experiment (6) left adrenal¬ 
ectomy followed 2 weeks after the ligature of the left kidney and 1 
week after the nephrectomy and adrenalectomy. After each operation and 
on the following day prophylactic doses of penicillin were given. 
Radio-thyroidectomy was accomplished by the intraperitoneal 
131 
injection of 1 mC I at least 10 weeks prior to the beginning of 
a given experiment. This dose is sufficient to produce a complete 
destruction of the thyroid gland with sclerosis in 30 days (Goldberg 







The sodium salt of thyroxine was dissolved in alkali and demineral¬ 
ized water and frozen in aliquots sufficient for daily 0.2 ml. s.q. 
injection for each experiment. 
Hydrocortisone was weighed out in daily aliquots and, on the 
day of use, dissolved in methyl alcohol and water for 0.2 ml. s.q. 
injections. Hydrocortisone had been shown (Thiedman et al, 1952, 1953) 
to have a smaller hypertensive effect than DOGA, and also not to be 
potentiated by 1$ saline to drink and unilateral nephrectomy. 
Upon death, the animals were examined grossly for kidney abscess, 
lung lesions, periarteritis and thyroid remanents. 
At termination of each experiment, except experiment (3), autopsies 
were performed, and the weight of the organs were d_etermined within five 
minutes of sacrifice. The organs were carefully trimmed and gently 
blotted before weighing. Values were expressed, as a percentage of 
body weight. 
Representative tissues were taken from several experiments and 
submitted for microscopic inspection. 
16 
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Preliminary experiments, using dose levels of 25 ug and 100 ug 
respectively, in animals -with reduced renal mass (figure-of-eight 
ligature of one kidney and contralateral nephrectomy) given Vfo saline 
to drink, had, in the first case (25 ug) shown little rise in hlood 
pressure and, in the second case (100 ug) had resulted in the early 
death of most of the rats. Thyroxine at 50 ug (s.q. over 7 day or 
longer periods) given to experimentally prepared animals resulted in 
a satisfactory rise in "blood pressure and relatively low mortality 
rate. 
In Experiment 1, the effect of thyroxine at 50 ug dosage on 
normal animals was tested. Earlier investigators (Bachtold, 1950 
and Krieger, 195&) had shown that thyroxine at 100-150 ug/day for 
more than two weeks and thyroxine at 117 ug/day for 21 days in 
normal animals caused a non-sustained rise in blood pressure. Did 
the 50 ug dose of thyroxine in experimentally prepared animals merely 
increase an effect which might be shown in normal animals? 
Eight male rats of the Institute strain weighing between 103 and 
151 grams were placed 2 per cage and given 1$ saline and regular diet 
ad lib. For 7 out of the following 10 days, normal or basal blood 
pressure determinations were made. On day 10, 5 of the rats were 
begun on thyroxine, 50 ug on 0.2 cc s.q. and the remaining 3 rats 
on O.O851° saline. Injections were carried out for 8 days and blood 
pressure was determined on days 11, 14, 16 and 17. On the day 
following the last injection (day 9) after the blood pressures were 







control group were sacrificed and kidney and heart weights determined. 
Body weights were measured at the beginning of the experiment, on 
the first day of injections,and at autopsy. Blood pressure determinations 
(Fig.2) are represented as averages of 2 days or 6 reading i.e. three 
individual readings per day x 2. 
RESULTS:  
TABLE 1: NORMALS (EFFECT OF 8 DAYS OF THYROXINE TREATMENT AT 50 ug 
Kidney 
(mg/o BW+ SD) 
Saline Control 
Thyroxine 
.523 + .014 
.554 + .027 
P > .6 
Heart 
(mg^b BN + 3D) 
.448 i .011 
.446 + .042 
p > .1 
Body Weight 
(cp change) 
+9.15 + 0.21 
+2.19 ± 7.65 
P > -3 
There were no significant differences in blood pressures, weight change 
or kidney and heart weight between the thyroxine and the saline treated 
group. 
Although the small number of animals precludes a strong statement, 
it appears the 50 ug dose of thyroxine over an 8 day period does not 
result in a significant change in the blood pressure of normal animals, 
nor in heart or kidney weight. 
19 




In an earlier work (Braun-Menendez, 1953) it was shown that the 
treatment of normotensive rats with moderate renal reduction (i.e. 
figure-of-eight ligature of one kidney, 4 to 5 months prior to therapy) 
with thyroxine (40 ug x 7 days) provoked a definite and in some cases 
sustained rise in blood pressure. In 3 normotensive rats, which had 
undergone figure-of-eight ligature of one kidney and contralateral 
nephrectomy 4-5 months previously, treatment with thyroid powder 
(15-25 mg qd x 10*l8) resulted in an increase in blood pressure. 
Although in the above animals there was no increase in blood 
pressure following the operations 4 to 5 months prior, there remains 
the question of changes having occurred inthe period before the be¬ 
ginning of thyroxine treatment which might have effected the results 
obtained, e.g. changes in kidney weight. Many workers have shown that 
once hypertension and/or its underlying vessel pathology have become 
established the effects of thyroxine therapy are changed. 
In the following experiment, an effort was made to determine 
1) the effects of thyroid administration on prepared animals, i.e. 
figure-of-eight ligature of one kidney and contralateral nephrectomy, 
during the latent period prior to the appeaj^ance of hypertension and 
2) the effects of adrenalectomy on the above treatment. The latter 
would possibly indicate whether the effects of thyroxine were directly 
upon kidney growth and function or indirect,!, e. -mediated through the 
adrenals. 
The dosage used (50 jig) gave no increase in blood pressure in 
normal animals (Experiment l). 
Materials and Methods 










(all but 5 between l40 and 206 grams) were divided into 5 groups. 
Four groups had figure-of-eight ligature of the left kidney followed 
one week later by right nephrectomy. Two of the four groups were 
adrenalectomized. Unilateral adrenalectomy ms performed with each 




Group I Ligature Left Kidney, Right Nephrectomy Saline controls 8 
Group II " " 11 " " Thyroxine 50 ug 14 
Group III n " " " ,Adrenal~x Saline controls 11 
Group IV n " " " k* Thyroxine 50 ug 20 
Group V Normal Controls Saline 5 
The rats were placed 2 per cage and given the regular Institute 
diet, and 1$ saline ad lib. The latter was measured as ml. consumed 
per 100 grams body weight. Injections were begun on the day following 
the last operation and lasted for 7 days. Autopsies were performed on 
the surviving animals four days after the final injections. Blood 
pressure was determined on the 2nd, 4th, 6th,, 8th and 10th days after 
the injections were begun. Blood pressure for the normal saline controls 
were taken on days 4, 8 and 10. 
RESULTS 
Survival 
Group I 8/8 
Group II ll/l4 
Group III 7/H 
Group IV 6/20 
Group V 5/5 
- 
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Blood Pressure In Both groups treated with thyroxine, the mean 
blood pressure was greater than the mean blood pressure of the saline 
groups. The significance of the blood pressure curves was determined 
by comparing three points in each group: day 2; the mean of days 4 and 
6; and the mean of days 8 and 10. In comparing groups I and II, only 
the last point on the graph was significantly different (p less than 
.02 and .01) (Figure 3)* In the nonaarenalectomized groups ( I & II) 
or groups with reduced renal mass only, both the saline and thyroxine 
treated groups had higher mean blood pressures than the normal controls; 
however in the two points compared, only the thyroxine treated group 
was significantly different ( p less than .01, less than .05).(Figure 4) 
In the adrenalectomized groups with reduced renal mass i.e. Ill and IV, 
the mean pressure of the normal rats fell between the saline and 
thyroxine treated groups but only the final point of the saline group 
was significantly lower. The thyroxine group mean blood pressure was 
not significantly higher. (Figure 4) 
Water Consumption: 
Water consumption between Group I and II was not significantly different. 
This also applied to Groups III and IV. However the mean of the saline 
consumption per 100 grams body weight of the two adrenalectomized groups, 
i.e. Ill and IV was lower than the group with reduced renal mass alone. 
Autopsy: Table 2 
Adrenals: The thyroxine treated group II was significantly higher 
than the normals (V), p less, than .02. The saline group (l) was 
higher but not significantly so. 
Kidneys: Both thyroxine treated groups II and IV were significantly 
heavier than their respective saline controls (Groups I and III) 
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I RRM* + 
Saline +9•30+6•6 .706+.050 .336+.038 .00210+.00045 .OO85+.0012 
II RRM + 
Thyroxine +2.45+7•2 .867+.136 .403+.045 .00295+.00086 .0099+.0030 
III RRM + Adrenal-x 
+ Saline -1.7 +5-0 ,718+.082 .308+.018 « .0099+.0021 
IV RRM + Adrenal-x 
+ Thyroxine -13.331,6.1 .890+.124 .3551*056 .0086+.0018 
V Intact Controls 
+ Saline +9 * 1+2.2 .419+.044 .289+.014 .00168+.00026 .0110+.0020 
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normal controls; all four graaps were significantly different (p less 
than .01 in all cases). Within the saline treated groups (I and III) 
adrenalectomy caused no significant change. There was also no significant 
change in the thyroxine treated groups (II & IV) 
THYROID: Adrenalectomized thyroxine treated group IV was significantly 
lighter than its respective saline control(lll) p <.01; but the non- 
adrenalectomized thyroxine treated Group II was significantly heavier 
than its saline control I, p< .01. All groups -with the exception of 
non-adrenalectomized thyroxine treated Group II were significantly 
lighter than the normal controls. The saline treated groups I and 
II and the thyroxine treated groups II and TV were not significantly 
different within their groups. 
HEART: Of the thyroxine treated groups only that with reduced renal 
mass without adrenalectomy (ll) was significantly higher than its 
operated control ( p< .05). When compared to the normal saline 
controls; all groups with the exception of Group III (reduced renal 
mass with adrenalectomy plus saline treatment) were significantly 
different. The saline groups and the thyroxine groups were not sig¬ 
nificantly different among themselves. 
WEIGHT: Both adrenalectomized groups lost weight and both non- 
adrenalectomized groups gained weight. Both thyroxine treated 
groups weighed less than their saline controls. With the slight 
exception of the saline treated non-adrenal-x animals; 1, the 
other groups weighed less than the normal saline controls. 
Experiment II demonstrates that in both adrenalectomized and non 
adrenal-x animals with reduced renal mass (i.e. figure-of-eight ligature 
and contralateral nephrectomy) thyroxine at a dose ineffective in 
normal animals is capable of raising blood pressure. Adrenalectomy; 

































































































Whereas thyroid treatment in hoth adrenalectomized and non- 
adrenalectomized rats caused increases in kidney weight both above 
respective saline and normal controls, there was no significant 
difference between the two thyroxine treated groups: this was also 
true for the saline controls. Only the hearts of the non-adrenal- 
ectomized thyroxine treated group were significantly increased above 
their saline controls. The adrenalectomized thyroxine treated rats 
and their saline controls showed no significant difference. There was 
no significant difference between the two thyroxine treated groups; 
this also held true for the saline treated groups. 
Thyroxine treatment significantly decreased the weight of the 
the 
thyroids (below their saline controls) in/adrenalectomized group; 
but in the non-adrenalectomized group, the thyroxine treatment increased 
thyroid weight above their saline controls. There was again no Ir¬ 
respective 
ference between the/thyroxine treated groups; nor between the respective 
saline groups. 
Thyroxine increased the weight of the adrenals significantly over 
the normals but not over the saline controls. Within the adrenalect¬ 
omized and non-adrenalectomized groups treated with thyroxine, although 
no significant differences existed, the kidney responded less in the 
non-adrenalectomized group and the heart less in the adrenalectomized 
group. Adrenalectomized animals, both thyroxine and saline treated, 
consumed less saline; however within both saline and thyroxine treated 
groups of the adrenalectomized and non-adrenalectomized subdivisions 
there were no significant differences. 
Further experiments will be necessary to assess the autopsy findings; 
however it seems that thyroxine is capable of reacting without the 
adrenals to raise blood pressure. 
•• l . . 
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This experiment repeats the preceding experiment (2) hut employs 
thyroidectomized. as well as adrenalectomized animals to eliminate 
possible influences of endogenous thyroid secretion. In the preceding 
experiment the thyroid glands in non-adrenalectomized animals with 
reduced renal mass were significantly increased over the saline controls 
with reduced renal mass following seven days of thyroxine treatment. 
Materials and Methods: Twenty-two white male rats of the Institute 
strain, weighing between l46 and 201 grams, except for two weighing 
127 and 2l6, were thyroidectomized with intraperintoneal injection of 
131 
1 mC I , seven weeks prior to the beginning of the experiment for the 
thyroxine group and 10 weeks prior to the onset for the saline group. 
The thyroxine treated group consisted of 10 animals. Figure-of-eight 
ligature of the right kidney and right adrenalectomy was followed nine 
days later by nephrectomy and left adrenalectomy. Injections of 50 jug/day 
thyroxine were begun on the day following the last operation and continued 
for seven days. The experiment was terminated two days after the final 
injections(nine days after the beginning of the experiment). The saline 
group consisted of 12 animals with the above operations and lasted the 
same time. Blood pressures were determined almost daily, except for 
day three in the thyroxine group and day four in the saline group. 
Autopsies were not performed and the animals were allowed to continue 
with periodic blood pressure determinations until death. 
Results: Survival (to ninth day) 
Thyroxine Group 5/l0 (l animal survived ih days after 
adrenale ctomy) 






Blood Pressure: (Figure 5) The thyroxine group blood pressure 
increased above its base during treatment and the saline group 
decreased below its pre-experimental levels during treatment. The 
curves (Figure 5) represent average of two days readings. The last 
two points on the graph are significantly different ( p less than .01) 
and the third from the end, not significant at p greater than .05. 
Weight Change: Weights declined but were not significantly different. 
The thyroxine treated group lost 12.1+ 13*8 per cent and the saline 
group lost 13*7 i. 15*0 per cent. 
It appears in this experiment that thyroxine maintained but did 
not increase significantly the blood pressure of both thyroidectomized 
and adrenalectomized rats with reduced renal mass. 
The mortality in both Experiments 2 and 3 reflects the delicate 
state of the animals. For this reason, a sustaining dose/was added 




This experiment repeats Experiment 2 using sustaining doses of 
hydrocortisone to attempt to improve survival rates and to bring the 
animals to a better state of physiologic balance than they were without 
any endogenous steroid. Friedman et al (1952, 1953) had demonstrated 
that hydrocortisone in uninephrectomized rats at .05 mg did not cause 
steroid hypertension nor was its action potentiated by 1$ saline 
as drinking, water. 
Materials and Methods 
Twenty-four white male rats of the Institute strain weighing 
between 127 and 188 grams were divided into two groups. In one, 
ligature of the left kidney and left adrenalectomy was followed one 
week later by right nephrectomy and adrenalectomy. The other group 
was operated upon at the same time but adrenalectomies were not per¬ 
formed. All rats were given 0.25 mg hydrocortisone on the day of the 
second operation and 0.5 mg thereafter. Both groups were subdivided 
into saline controls and thyroxine treated animals. The thyroxine 
groups received 50 thyroxine daily beginning the day after the 
last operation and lasting for fourteen days. The hydrocortisone was 
continued for two days beyond and the survivors were sacrificed on 
the next day or seventeen days after adrenalectomy. 
Blood pressures were determined on days 3> 4,5j> 7_>9jH>14 and l6 
after the second operation. The animals were given 1$ saline ad lib. 
Results: 
Survival (After Seventeen Days) 




Group II ™ Reduced Renal Mass, Adrenalectomy -■ Thyroxine 4/9 
Group III- Reduced Renal Mass - Saline 2/3 
Group IV - Reduced Renal Mass - Thyroxine 4/4 
Blood Pressure: In the non-adrenalectomized group there was no difference 
Between the thyroxine group and saline controls. In the adrenalectomized 
group, the mean thyroxine hlood pressure was higher than the saline 
control, only the last point on the curve showed a significant difference 
f 
(p < .05) - however Blood pressures of Both groups fell during the course 
of the experiment. 
Autopsy: (Table 3) 
Kidney: In Both adrenalectomized and nonadrenalectomized groups, 
thyroxine treated kidneys were heavier than their saline controls. But 
only significantly so ( p<.Ol) in the adrenalectomized group. The 
Body weight of the nonadrenalectomized thyroxine treated group was 
significantly heavier than-the saline injected adrenalectomized group 
( P < .02) . 
Heart: The saline treated adrenalectomized group I was signi¬ 
ficantly lighter than all other groups. 
Thyroid• The mean thyroid weights in the thyroxine treated Groups 
II and IV were lower than their respective saline controls, But not 
significantly so. There was also no significant difference Between 
the thyroxine treated groups themselves (II vs. IV) or the saline 
controls (l vs. III). 
Adrenals: The thyroxine treated group mean adrenal weight was 
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EXPERIMENT 4 TABLE 3 
Group and No. Weight Kidney Heart Adrenal Thyroid 
I RRM*, 
adrenal-x 
$ Change mg i mg % mg % mg io 
+ Saline (5) 
II RRM, 
adrenal-x 
+2.85*7.1 .740*.062 .332*.052 .0138*.0022 
+ Thyroxine (4) +1.4*11.8 .881*.033 .444*.063 .0119*.0019 
III RRM 




+ Thyroxine (4) +2.36=fcl4.5 .849*.057 .449*.078 ,00252* .0127*.0030 
* RRM = Reduced Renal Mass (Figure-of-eight ligature of one kidney and 




Weight: All groups gained weight hut exhibited no significant 
differences when compared. 
The poor results obtained in Experiment IV as opposed to Experiment 
II with regard to blood pressures correlate with the poor differences 
exhibited by the kidney and other organs at autopsy. This experiment 
is repeated in Experiment V using a different strain of animals and 




Earlier work by Lascano-Gonzalez (193^) on rats of the Institute 
strain had demonstrated the appearance of accessory adrenal glands in those 
rats which survived bilateral adrenalectomy. The maximum adrenal insuf¬ 
ficiency occurred five to fifteen days post-operatively. It was with the 
intent of avoiding adrenal secretions from the accessory glands that all 
experiments reported - except this one which was carried out on a different 
strain - were never carried beyond two to three weeks. However;, it was 
reported that the Wistar rats of the Argentine Atomic Energy Commission 
strain did not exhibit any significant accessory adrenal growth post 
adrenalectomy. This allowed the carrying out of a more prolonged experiment 
with adrenalectomized rats on sustaining doses of hydrocortisone which 
would repeat with a greater chance of success the previous experiment (4). 
Materials and Methods: 
Eighteen male Wistar rats weighing between 147 and 167 grams were 
divided into two groups. Group I consisted of eight operated saline controls 
and Group II, of 10 operated thyroxine treated experimentals. Ligature of 
the left kidney and simultaneous left adrenalectomy was followed one week 
later by combined right adrenalectomy and nephrectomy. On the day prior to 
the second operations, Groups I and II were begun on 0.5 mg hydrocortisone 
s.0.; this dose was continued until the twelfth day after the second 
operation whenit was decreased to 0.25 mg* this later dose continuing 
daily until the end of the experiment. On Day One following the second 
operation, Group II was begun on 10 ug thyroxine s.q.; on Day Thirteen, 
this was increased to 25 ug; and on Day Twenty-five, this was again 
increased to 50 ug, this last dose continuing for eight days -until the 
end of the experiment. The hydrocortisone at 0.25 mg was continued for 
two days beyond the termination of thyroxine therapy. On the Thirty-fourth 
day after the second operation, the animals were sacrificed. 
( • ) 
- 
.!>£? ’ S. . 
— 
... . 
. . i " '■ 
|h'j 





- • T ' 
• • ' 
• 
. ■ 





All animals were kept in individual cages and given ad lib food 
and 1$ saline. The blood pressures of Groups I and II were measured every 
second day. Autopsies were performed in the usual manner using the 
Roller-Smith Balance. Four normal untreated animals with pressure in the 
normal range were also sacrificed. 
Results: 
Survival: All animals, except one in the Saline treated Group I, 
survived. 
Blood Pressure: (Figure 6) Determinations are represented as the 
average of the mean o f two successive days' readings. Approximately midway 
in the course of the treatment with the dose level of 10 ug thyroxine, the 
thyroxine Group II had a higher mean blood pressure than the Saline control. 
This difference was maintained until the end of the experiment; however, 
only the last two points on the graph were significantly different 
(p <.01 and p < .05). 
Weights: Both Groups I and II gained weight. Group I, +50.1*6.1 
per cent and Group II, 37.8*2,4 per cent. This represented a statistically 
significant difference of p < ..05 in favor of the saline controls. 
Autopsy: 
Kidneys: Both operated Groups I and II were significantly 
(p < .01) heavier than the normals; and the thyroxine treated Group II was 
significantly heavier (p <.0l) than its saline control Group I. 
Heart: The thyroxine treated Group II was significantly heavier 
than both its saline control Group I ( p<.ol) and the normal controls. (p< .01) 
The saline control Group I, however, was not significantly heavier than the 
normal controls ( p<.05). 
Thyroid: The only significant difference existed between the thyrox¬ 
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EXPERIMENT 5 
Group and No. 
TABLE 4 
Weight Kidney Heart Thyroid 
$ Change mg<f> mg$> mg$ 
Intact 
Controls (4) — .4l4*.005 •3025±.oi4 .0120*.0004 
RRM, Adrenal-x 
Saline (7) +50.1*6.1 ,685*.024 •348±.Ol6 .0106*.0008 
RRM*, Adrenal-x 
Thyroxine (lO) +37.8*2.4 .820*.018 .413*.031 .0083*.ooo4 
*KRM (Reduced Renal Mass = Figure-of-eight ligature 
of one kidney and contralateral nephrectomy) 
. 
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Experiment 5 again exhibits the ability of thyroxine to increase 
blood pressure in adrenalectomized rats with reduced renal mass. 
With sustaining doses of hydrocortisone, the saline group maintained an 
almost normal blood pressure level. This gives more significance 
to the rise in blood pressure of the thyroxine treated group. 
. 
EXPERIMENT 6 
This experiment repeats the earlier Experiment (3) using sustaining 
doses of hydrocortisone in thyroidectomized and a.drenalectomized rats 
with reduced renal mass. 
Materials and Methods 
Ten white male rats of the Institute strain, weighing between 136 
131 
and 165 grams., which bad been given 1 mC I ' nine weeks prior to the onset 
of the experiment were subjected to the following operations: l) Figure- 
of-eight ligature of the left kidney, followed seven to,nine days later by 
2) Right Adrenalectomy and Right Nephrectomy, followed four to six days 
later by 3) Left Adrenalectomy. 
The animals were divided into two groups: Group I: Five animals 
received hydrocortisone and saline, and Group II: Five animals received 
thyroxine and hydrocortisone. One mg hydrocortisone was given on the day 
of the last operation in divided doses and a sustaining 0.5 mg divided 
daily dose thereafter. Saline and thyroxine (50 ug) injections were begun 
on the day following the last operation and continued for twelve days. 
The hydrocortisone was continued two days beyond that. 
Animals were kept in separate cages and given normal chow and 1’jo 
saline to drink. Autopsies were performed on the day following the last 
hydrocortisone injection or sixteen days after complete adrenalectomy. 
Blood pressures were determined each second day after the last operation. 
Kidneys and hearts were weighed and the thyroid region inspected grossly. 
Results 
Survival: 
Group I: RRM, Adrenal-x, Thyroid-x + Saline 3/5 
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EXPERIMRTW 6 TABT.F 5. Adrenalectomized, Thyroidectomized Rats with 
Reduced Renal Mass 






Group I - 
Saline + 
Hydrocort.(4) -3.3*8.4 .611*.033 .371*.o4i 
Group II 
Thyroxine + 
Hydrocort.(3) -4.4±1.8 .739*-084 .393*.027 
Results (cont.) 
All animals shoved no evidence of thyroid tissue grossly. 
Blood Pressure: (Figure 7) The thyroxine treated group shoved, an 
increase in blood pressure over the saline treated group. The last tvo 
points on the graph vere significantly different, p<.05 and p<.ol, 
respectively. 
Body Weight: Both groups lost veight. Group II (Thyroxine) -4.4±1.8 
per cent and Group I )(Saline) -j3.3*8.4. These differences vere not 
significant. 
Autopsy: The Kidneys in the thyroxine treated, group vere significantly 
heavier (p<.05) than the saline group. The Hearts in the thyroxine 
treated group vere also heavier than the saline treated group but not 
significantly so. 
It has again been demonstrated, that thyroxine can increase above 
normal the blood pressure of adrenalectomized rats. This continues to cor¬ 
relate veil vith the increase in kidney veight and less veil vith the increase 
in heart veight. 
A compilation of many determinations of blood pressure shoved the 
distribution curve of thyroidectomized animals to be lover than that of 
normal animals. The curve for the normal animals gives good agreement -7 
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It has been demonstrated that thyroxine treated rats with figure- 
of-eight ligature of one kidney and unilateral nephrectomy, which have 
been adrenalectomised or both adrenalectomized and thyroideatomized, 
show a restoration of blood pressure to above normal or slightly 
hypertensive levels* This occurred at a dose level ineffective In 
normal animals. This also occurred during the lag phase prior to the 
time of the usual appearance of experimental renal hypertension. The 
effect on blood pressure of thyroxine was augmented by supplying sustain- 
epects 
ing doses of hydrocortisone. In experiment the longer term/of thyroxine 
administration were amply demonstrated. These results were enhanced when 
compared to the saline controls because of the decrease, quite large in 
several instances, of blood pressure below normal levels. 
Treatment of adrenalectomized rats with thyroxine increased the 
mortality, as had previously been shown (Zwemer, 1927; Hoffman et al, 
1948), This was also true of adrenalectomized-thyroidectomized rats 
treated with thyroxine. Sustaining doses of hydrocortisone given 
to such animals, however, decreased the large mortality, confirming 
Koelsche and Kendall (3,935). 
In Experiments 2 and 4,adrenalectomy did not cause any significant 
difference in the effects produced by thyroxine on kidney, heart and 
thyroid weight. With the exception of Experiment 4, thyroxine caused 
a significant increase in kidney weight over both saline and normal 
controls in the adrenalectomized and also in the nonadrenalectomized 
groups. This was well correlated with the effect on blood pressure. 
The effect of thyroxine on heart weight was less striking (Tables 4^5). 
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but the difference was not significantly greater than the saline 
controls. This is in agreement with Pekkarinen. et al, 1951 j Preston 
1928; and Ingle and Higgins, 1938. 
Except for the adrenalectomized rats in Experiments 2 and 4, 
thyroxine caused the non-adrenalectomized rats to gain less weight 
than their saline controls; and all adrenalectomized thyroxine treated 
rats to lose more weight than their saline controls. 
As for 1 c/o saline drinking water, thyroxine made no significant 
difference between saline or thyroxine treated groups, whether these 
animals were adrenalectomized or not. 
Microscopic examination of tissues taken from autopsied animals 
failed to show any significant histopathological difference between 







That thyroxine has a hypertensive effect on animals with reduced 
renal mass has been confirmed. That thyroxine has a definite if not 
marked effect on adrenalectomized animls with reduced renal mass has 
also been demonstrated. The effect on blood pressure in the absence 
of adrenals is quantitively less; however, the renotrophic effect is 
statistically undiminished. Accepting the role of the kidney in 
experimental renal hypertension, one finds that the adrenals are 
qualitatively unnecessary for renal hypertrophy; and hence their effect 
on increased blood pressure is quantitative or "permissive'1. 
If the adrenal’s role is minimized, it is interesting to investi¬ 
gate other possible factors in the mechanism of thyroid action. 
Brewster (195*0 and Page and McCubbin (1952) showed a correlation 
between thyroid activity and the sensitivity of the heart and blood 
vessels of dogs to infusions of catecholamines. The same was demonstrated 
in rats by Osorio (1956)* The effect of such changes in vascular re¬ 
activity or increased secretion of catecholamines seems of minor rather 
than major importance here. In Experiment 1, a 50 jig dose of thyroxine 
given to normal animals had no measureable effect on blood pressure. 
In Experiment 5 which lasted over a month, it would be hard to concede 
a major role to a continuing change in vascular reactivity (without 
histologic change) or increased secretion of catecholamines, 
especially in adrenalectomized animals. Other investigators (Alpert, 
1937; Pickering, 1955; Von Euler, 1956) have found no change in levels 
of catecholamines in experimental renal hypertension. 
Thyroxine’s effect in increasing heart weight is well known. 
Sandler and Wilson (1959) studying the production of cardiac hypertrophy 
by thyroxine in the rat found that increased heart weight was due to 
muscle hypertrophy and not to changes in water or electrolytes. The 
response of the heart was secondary to an increased metabolic rate and 
4l 
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and hence demand for oxygen (Rasmussen, 1941). Krieger(l956) found 
that dinitrophenol increased oxygen consumption; however, it was only 
thyroxine that increased blood pressure. 
Fregly and Gonzales (1961) found that oxygen consumption in renal 
hypertensive rats did not have a close relationship to systolic blood 
pressure. These authors asked whether the thyroid weight ratio increased 
in response to a rising systolic blood pressure or to an increasing 
heart weight ratio. In our experiments, studying the lag period before 
the appearance of hypertension, the thyroxine injections were effective 
in the absence of both prior increase in blood pressure and cardiomegaly. 
There is no doubt that adrenalectomy decreased the vitality of 
our experimental animals, and hence lessened the effect of thyroxine 
or rather increased mortality to these injections. Sustaining doses 
of hydrocortisone, however, improved the experimental conditions and 
hence the ability of thyroxine to enhance renal hypertension in the 
absence of adrenal glands. 
Further study of the role of the thyroid in experimental renal 
131 
hypertension are indicated. Over a period one might study I uptake; 
the changes in content of thyroid hormones in the gland and plasma; 
the histology of the thyroid during the course of development of renal 
hypertension; and respiration in various organs and tissues during the 
phases of hypertension, thyroid hyperfunction and adrenal insufficiency. 
Very little is known about the early stages in experimental renal 
hypertension. As in humans, once hypertension becomes established the 
factors that may have given rise to it diminish, in importance. Green et al 





(1952) demonstrated the un-importance of both the adrenal and the 
thyroid in post DCA hypertension. In humans, thyroidectomy (Kountz 
and Humpelmann, 19^0) and antithyroid drugs (Beamish and Adamson, 
19^5) failed to lessen established, hypertension. The future seems 
to lie more clearly with the prevention rather than the treatment 
of the disease. And. it is to that end that studies of the many 






Ha sido demostrado que en ratas con ligadura en ocho de un rinon 
y nefrectomia contralateral y que han sido adrenalectoraizadas o adrenal¬ 
ectomizadas y tiroidectomizadas; el tratamiento con tiroxina les determina 
un restablecimiento de la presion arterial, en niveles por encima de lo 
normal o discretamente hipertensivos. Este efecto se observe, durante la 
fase previa a la aparicion de hipertension con dosis que no producen 
modificaciones en animales normales. El efecto de la tiroxina sobre la 
presion arterial fue potenciado por la hidrocortisona en las dosis 
habituales de mantenimiento. 
El tratamiento con tiroxina determino una mortalidad aumentada en las 
ratas adrenalectomizadas o adrenalectomizadas y tiroidectomizads,s; las 
dosis de mantenimiento de hidrocortisona disminuyeron el grado de mortalidad. 
El efecto de la tiroxina sobre el peso del rinon , del corazon 
y de la tiroides no fue modificado significativamente por la adrenalectomia. 
El efecto de la tiroxina sobre la presion arterial tuvo una buena 
correlacion con el grado de hipertrofia renal conseguido con el tratamiento. 
Han sido discutidos los posibles mecanismos de accion del efecto 
encontrado, presentandose tambien un resumen de la literatura sobre el 
papel de la tiroides en la hipertension renal experimental. 
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